InsiderClue
Insiders · Profile

SETH SANDESH

Chairman & CEO at Actinium Pharmaceuticals · Director at RELMADA THERAPEUTICS. Filing since 14 Dec 2015. CIK 0001566175

ATNM Actinium Pharmaceuticals, Inc. Chairman & CEO · 10 trades RLMD RELMADA THERAPEUTICS, INC. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ATNM Actinium Pharmaceuticals, Inc.
10 Dec 2018
Chairman & CEO
Bought
10,000
$4.37K
7.0%
ATNM Actinium Pharmaceuticals, Inc.
17 Jul 2018
CEO
Bought
10,000
$7.90K
7.5%
ATNM Actinium Pharmaceuticals, Inc.
19 Apr 2018
Chairman & CEO
Bought
5,000
$1.90K
3.9%
ATNM Actinium Pharmaceuticals, Inc.
2 Aug 2017
Chairman & CEO
Bought
33,333
$25.00K
78.4%
ATNM Actinium Pharmaceuticals, Inc.
15 Jun 2017
Chairman and CEO
Bought
7,500
$8.73K
21.4%
ATNM Actinium Pharmaceuticals, Inc.
30 Dec 2016
Executive Chairman
Bought
5,000
$4.40K
16.7%
ATNM Actinium Pharmaceuticals, Inc.
12 Dec 2016
Executive Chairman
Bought
5,000
$4.90K
20.0%
ATNM Actinium Pharmaceuticals, Inc.
18 Apr 2016
Director
Bought
6,500
$12.89K
35.1%
ATNM Actinium Pharmaceuticals, Inc.
15 Apr 2016
Director
Bought
3,500
$7.02K
23.3%
ATNM Actinium Pharmaceuticals, Inc.
14 Apr 2016
Director
Bought
5,000
$10.00K
50.0%
RLMD RELMADA THERAPEUTICS, INC.
15 Dec 2015
Director
Bought
9,500
$30.31K
8.4%
RLMD RELMADA THERAPEUTICS, INC.
14 Dec 2015
Director
Bought
10,500
$30.73K
10.2%
12 decisions on file.